Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.
Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P. Tozzi V, et al. Among authors: vlassi c. AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13. doi: 10.1089/aid.2005.21.706. AIDS Res Hum Retroviruses. 2005. PMID: 16131310
Interferon may prevent HIV viral rebound after HAART interruption in HIV patients.
Dianzani F, Rozera G, Abbate I, D'Offizi G, Abdeddaim A, Vlassi C, Antonucci G, Narciso P, Martini F, Capobianchi MR. Dianzani F, et al. Among authors: vlassi c. J Interferon Cytokine Res. 2008 Jan;28(1):1-3. doi: 10.1089/jir.2007.0076. J Interferon Cytokine Res. 2008. PMID: 18370866 Clinical Trial.
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.
Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P. Tozzi V, et al. Among authors: vlassi c. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82. doi: 10.1097/QAI.0b013e318042e1ee. J Acquir Immune Defic Syndr. 2007. PMID: 17356465
Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.
Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P. Tozzi V, et al. Among authors: vlassi c. J Neurovirol. 2005 Jul;11(3):265-73. doi: 10.1080/13550280590952790. J Neurovirol. 2005. PMID: 16036806
Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A. Tozzi V, et al. Among authors: vlassi c. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63. doi: 10.1097/qai.0b013e3181af83d6. J Acquir Immune Defic Syndr. 2009. PMID: 19731418
88 results